Blisovi 24 Fe NDC 68180-864

NDC codes

FDA NDC Directory

Product NDC (as listed)68180-864Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68180-0864Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68180-864-73	68180086473	3 BLISTER PACK in 1 CARTON (68180-864-73) / 1 KIT in 1 BLISTER PACKMarketed from Nov 7, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Blisovi 24 Fe
Generic name (nonproprietary): norethindrone acetate and ethinyl estradiol
Dosage form: Kit
Labeler: Lupin Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091398
Marketing start: Nov 7, 2019
Listing expires: Dec 31, 2026
Identifiers: Product ID 68180-864_934a273b-4e1e-4b97-972f-71cdf6be0e05SPL ID 934a273b-4e1e-4b97-972f-71cdf6be0e05SPL set ID 1183b048-16f3-47a4-a42f-22ba07b2bb52RxCUI 259176, 1358762, 1359117, 1722680UPC 0368180864714

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N468180086473 followed by a unit qualifier and the quantity

Package 68180-0864-73. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 18, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Blisovi ™ 24 Fe is indicated for use by women to prevent pregnancy [see CLINICAL STUDIES ( 14 )]. The efficacy of Blisovi 24 Fe in women with a body mass index (BMI) of > 35 kg/m 2 has not been evaluated. Blisovi 24 Fe is a combination of norethindrone acetate, a progestin, and ethinyl estradiol, an estrogen, indicated for use by women to prevent pregnancy. (1) The efficacy of Blisovi 24 Fe in women with a body mass index (BMI) of >35 kg/m 2 has not been evaluated. ( 1 , 8.8 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)